| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research | Officer Level 14 | EVP, Research +1 more
1 company
Swayze Eric is an EVP Research at IONIS PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 12,680 | $51.63 | $654,709.40 | -15.9% | -13.4% | -35.9% | |
| Jan 17, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 6,305 | $50.42 | $317,879.19 | -12.7% | -19.0% | -37.1% | |
| Dec 28, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 27,100 | $50.19 | $1,360,081.25 | -45.5% | -11.6% | -28.9% | |
| Oct 17, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 52 | $47.95 | $2,493.35 | -41.6% | +5.2% | -19.3% | |
| Feb 6, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 1,815 | $40.79 | $74,031.31 | -5.4% | -13.1% | +21.3% | |
| Jan 18, 2023 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 5,631 | $39.74 | $223,799.59 | -15.8% | -8.6% | +27.2% | |
| Sep 8, 2022 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 460 | $44.55 | $20,493.00 | -2.3% | -13.7% | -6.9% | |
| Aug 5, 2022 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 1 | $45.20 | $45.20 | - | -2.6% | -13.0% | |
| Apr 21, 2022 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 378 | $44.15 | $16,688.70 | -1.8% | -9.3% | -14.1% | |
| Jan 5, 2021 | IONS Ionis Pharmaceuticals Inc | EVP, Research | Sell | 195 | $55.99 | $10,918.05 | -3.7% | - | - |